DUBLIN, Sept 17 (Reuters) - The board of Elan (ELN.I) has been cleared of any wrongdoing following a controversial review by a U.S. law firm, the Irish drugmaker said on Friday, adding that two directors would resign following the inquiry.
DUBLIN, Sept 17 (Reuters) - The board of Elan (ELN.I) has been cleared of any wrongdoing following a controversial review by a U.S. law firm, the Irish drugmaker said on Friday, adding that two directors would resign following the inquiry.